Source:http://linkedlifedata.com/resource/pubmed/id/10098674
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1999-5-24
|
pubmed:abstractText |
A novel synthesis of the bicyclo [2.2.2] octane ring system has been achieved utilising a tandem Henry cyclisation as the key stage. This chemistry has been employed in the synthesis of a potential inhibitor of influenza virus sialidase.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0960-894X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
22
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
611-4
|
pubmed:dateRevised |
2001-11-2
|
pubmed:meshHeading | |
pubmed:year |
1999
|
pubmed:articleTitle |
Synthesis of a tetrasubstituted bicyclo [2.2.2] octane as a potential inhibitor of influenza virus sialidase.
|
pubmed:affiliation |
Department of Enzyme Medicinal Chemistry II, Glaxo Wellcome Medicines Research Centre, Stevenage, Herts UK. PS5776@GGR.CO.UK
|
pubmed:publicationType |
Journal Article
|